跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABRAXANE - SFDA Drug Approval Details
Approvals
/
SFDA
/
ABRAXANE
Authorized
NCE
ABRAXANE
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
c99342051d4e23ac
Company
Unknown
Type
NCE
Approval Details
Approval Id
c99342051d4e23ac
Drug Approval Sfda Name
ABRAXANE
Trade Name
ABRAXANE
Generic Name
PACLITAXEL
Register Number
9-5550-22
Register Year
2020
Drug Type
NCE
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
20
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000000950-5-200000017703
Price
1157.05
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
c99342051d4e23ac
Type
NCE
Back to SFDA Approvals